ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $241,208,570 | -10.2% | 8,887,567 | +1.7% | 0.03% | -6.9% |
Q2 2023 | $268,549,912 | -14.0% | 8,736,171 | +0.7% | 0.03% | -23.7% |
Q1 2023 | $312,436,000 | +93739.6% | 8,671,563 | +2.9% | 0.04% | -13.6% |
Q4 2022 | $332,947 | -99.9% | 8,424,747 | +1.1% | 0.04% | -8.3% |
Q3 2022 | $334,764,000 | +4.1% | 8,331,597 | +8.9% | 0.05% | +6.7% |
Q2 2022 | $321,522,000 | +48.4% | 7,647,985 | +37.6% | 0.04% | +73.1% |
Q1 2022 | $216,592,000 | +0.2% | 5,559,388 | +2.5% | 0.03% | +4.0% |
Q4 2021 | $216,075,000 | +12.5% | 5,422,203 | +2.0% | 0.02% | +4.2% |
Q3 2021 | $192,138,000 | -35.9% | 5,316,482 | -27.3% | 0.02% | -33.3% |
Q2 2021 | $299,842,000 | +18.6% | 7,315,001 | +26.2% | 0.04% | +5.9% |
Q1 2021 | $252,790,000 | -16.9% | 5,795,267 | -4.7% | 0.03% | -24.4% |
Q4 2020 | $304,322,000 | +93.1% | 6,080,359 | +62.1% | 0.04% | +73.1% |
Q3 2020 | $157,590,000 | -12.8% | 3,751,236 | +0.7% | 0.03% | -25.7% |
Q2 2020 | $180,797,000 | – | 3,723,924 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |